Results 241 to 250 of about 375,473 (301)

Contesting Cannabis Legalization in Nigeria: Hidden Narratives of Illicit Farmers and Traders

open access: yesSociological Inquiry, Volume 95, Issue 2, Page 235-251, May 2025.
This article examines narratives of cannabis legalization in Nigeria. While most existing research on cannabis legalization has concentrated on the global North, we focus on one of Africa's largest cannabis markets, as well as the views of actors heavily criminalized and excluded from policy debates.
Ediomo‐Ubong Nelson   +1 more
wiley   +1 more source

Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial

open access: hybrid, 2017
Adrian Dunlop   +13 more
openalex   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Naloxone in heroin dependence

Clinical Pharmacology & Therapeutics, 1968
Naloxone is a potent and rapidly acting narcotic antagonist, with a duration of action which is shorter (3 to 4 hours) than that of heroin. In a clinical trial of naloxone in the treatment of heroin dependence, a daily oral dose of 100 mg. at 8 A.M. and 7 P.M. effectively blockaded 20 mg.
Arnoldo Mora   +6 more
openaire   +3 more sources

Acute effects of heroin on emotions in heroin‐dependent patients

The American Journal on Addictions, 2013
BackgroundEuphoria has been described in heroin‐dependent individuals after heroin administration. However, affective disturbances and disorders are common in heroin dependence. The present study examined the acute effects of heroin on emotions in heroin‐dependent patients.MethodsThis randomized controlled crossover trial included 28 heroin‐dependent ...
Blum, J.   +8 more
openaire   +4 more sources

Buprenorphine and Naloxone for Heroin Dependence

Current Psychiatry Reports, 2000
The pharmacology of buprenorphine is unique because of its partial agonist profile at the mu-opioid receptor (ie, high affinity, low intrinsic activity and slow dissociation). This unique profile results in greater safety, less physical dependence, and greater flexibility in dose scheduling.
Jeffrey C. McCagh, Rolley E. Johnson
openaire   +3 more sources

Home - About - Disclaimer - Privacy